Head-to-head · Value Score
CoreAge Rx vs Livv
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Livv a 73. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameLivv
#172 · Grade C+ · Watch List
Est. first month
$159/mo month-to-month ($135/mo on a 6-month plan)
Save ~88% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 73 — an est. $99/mo first month, with no teaser step-up baked in. Livv isn't out of it: Someone outside the six states Livv does not cover who wants a dose-independent price with everything bundled.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Livv |
|---|---|---|
| Value Score | 93 (A+) | 73 (C+) |
| Est. first month | $99/mo | $159/mo month-to-month ($135/mo on a 6-month plan) |
| Save vs brand-name | ~89% | ~88% |
| Semaglutide | $99/mo | $159/mo month-to-month ($135/mo on a 6-month plan) |
| Tirzepatide | $149/mo | From $249/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | 44 states and Puerto Rico |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Livv
Livv is a subscription telehealth service selling compounded semaglutide from $135 to $159 a month depending on plan length, alongside a longevity line of rapamycin, NAD+ and metformin.
Why it's a deal
- The full plan ladder is published - $159 month-to-month, $145 on three months, $135 on six - so the cheapest figure is not the only one shown
- Same price at every dose, with consultation, visits, ongoing support, shipping and supplies all inside the quoted rate
- Says plainly which states it does and does not serve, and lists all 44 by name rather than claiming nationwide coverage
- A month-to-month option exists at $159, so the cheaper rungs are a choice rather than the only way in
The fine print
- Not available in all 50 states - Livv serves 44 plus Puerto Rico, and California, Alabama, Arkansas, Indiana, South Carolina and West Virginia are excluded
- The $135 headline needs six months paid up front; month-to-month costs $24 more
- Tirzepatide is listed only as "from $249" with no plan ladder beside it, so the cheaper rungs may not apply to that molecule
- Compounded only, sold beside a longevity catalog of rapamycin, glutathione and NAD+, so weight loss is one line in a broader menu
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Livv.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.